ViCardia Therapeutics, Inc.
Biotechnology company · San Francisco, California, United States
ViCardia Therapeutics, Inc. is a biotechnology company headquartered in San Francisco, California, United States. It has reported private securities offerings to the US SEC, most recently $700,000 sold in a notice filed in 2026.
Profile compiled from public records. Is this your company? Request a correction or update
ViCardia Therapeutics at a glance
Typebiotechnology company
HeadquartersSan Francisco, California, United States
SEC CIK2135564
What does ViCardia Therapeutics do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $700,000 sold (2026).
Frequently asked questions about ViCardia Therapeutics
Where is ViCardia Therapeutics headquartered?
ViCardia Therapeutics, Inc. is headquartered in San Francisco, California, United States.
What does ViCardia Therapeutics do?
ViCardia Therapeutics, Inc. is a biotechnology company.
Similar companies
- Ossium Health, Inc.San Francisco, California, United States
- Vir Biotechnology, Inc.San Francisco, California, United States
- Titan Pharmaceuticals IncSan Francisco, California, United States
- Senti Biosciences, Inc.San Francisco, California, United States
- Amygdala Neurosciences IncSan Francisco, California, United States
- Excision BioTherapeutics IncSan Francisco, California, United States
- ProLynx, Inc.San Francisco, California, United States
- Second Genome, Inc.San Francisco, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences